The Impact of Ketoanalogues on Nephropathy Progression in Advanced Chronic Kidney Disease Older Patients

datacite.rightshttp://purl.org/coar/access_right/c_abf2spa
dc.contributor.authorAroca-Martinez, Gustavo
dc.contributor.authorSierra, Angélica
dc.contributor.authorBarros-Camargo, Luis
dc.contributor.authorPertuz-Pinzon, Adolfo
dc.contributor.authorDianda, Daniela
dc.contributor.authorCadena-Bonfanti, Andrés
dc.contributor.authorMusso, Carlos G.
dc.date.accessioned2022-12-06T19:54:42Z
dc.date.available2022-12-06T19:54:42Z
dc.date.issued2022
dc.description.abstractAdvanced chronic kidney disease (CKD) can be treated with conservative care or renal replacement therapies. CKD is associated with an increased risk of nephropathy progression, and death. Therefore, slow down CKD progression is crucial, and there is consensus regarding protein intake regulation benefit in delaying this progression. Ketoanalogues are nitrogen-free analogs of essential amino acids which supplements low protein diets. Thus, it was decided to evaluate if keto diet had benefit in reducing CKD progressioneng
dc.format.mimetypepdfspa
dc.identifier.doiDOI: 10.31080/ASNH.2022.06.1156spa
dc.identifier.issn25821423
dc.identifier.urihttps://hdl.handle.net/20.500.12442/11632
dc.identifier.urlhttps://www.actascientific.com/ASNH/pdf/ASNH-06-1156.pdfeng
dc.language.isoengeng
dc.publisherActa Scientific Publicationseng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceActa Scientific Nutritional Healtheng
dc.sourceAct. Sci. Nutr. Healtheng
dc.sourceVol. 6 No. 12 (2022)eng
dc.subjectChronic Kidney Diseaseeng
dc.subjectKetoanalogueseng
dc.subjectProgressioneng
dc.titleThe Impact of Ketoanalogues on Nephropathy Progression in Advanced Chronic Kidney Disease Older Patientsspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.spaArtículo científicospa
dcterms.referencesScalone L., et al. “Cost-benefit analysis of supplemented very low-protein diet versus dialysis in elderly CKD5 patients”. Nephrology Dialysis Transplantation 25 (2010): 907-913eng
dcterms.referencesPerez-Gomez MV., et al. “Clarifying the concept of chronic kidney disease for non-nephrologists”. Clinical Kidney Journal 12.2 (2019): 258-261eng
dcterms.referencesMusso CG and Jauregui JR. “How to differentiate renal senescence from chronic kidney disease in clinical practice”. Postgraduate Medicine 128.7 (2016): 716-721.eng
dcterms.referencesChen TK., et al. “Chronic kidney disease diagnosis and management. A Review”. JAMA 322.13 (2019): 1294-1304.eng
dcterms.referencesBrunori G. “Treatment of chronic kidney disease in the elderly: diet or conservative management”. Journal of Nephrology 25.19 (2012): S28-S31.eng
dcterms.referencesMusso CG., et al. “Therapeutic alternatives and palliative care for advanced renal disease in the very elderly: a review of the literature”. International Urology and Nephrology 47.4 (2015): 647-654.eng
dcterms.referencesBellizzi V., et al. “A Delphi consensus panel on nutritional therapy in chronic kidney disease”. Journal of Nephrology 29.5 (2016): 593-602.eng
dcterms.referencesCuppari L., et al. “A practical approach to dietary interventions for nondialysis-dependent CKD patients: The experience of a reference nephrology center in Brazil”. BMC Nephrology 17.1 (2016): 1-11.eng
dcterms.referencesSánchez C., et al. “Influence of low-protein dietetic foods consumption on quality of life and levels of B vitamins and homocysteine in patients with chronic renal failure”. Nutricion Hospitalaria 25.2 (2010): 238-244.eng
dcterms.referencesEspinosa-Cuevas M and Correa-Rotter R. “[Renal alterations and Nutrition] In Arroyo, Kaufer Horowitz, Perez Lizaur (Eds)”. Nutriologia Médica. Buenos Aires. Editorial Panamericana (2015): 695-730.eng
dcterms.referencesBernhard J., et al. “Adaptive response to a low-protein diet in predialysis chronic renal failure patients”. Journal of the American Society of Nephrology 12.6 (2001): 1249-1254eng
dcterms.referencesWalser M and Hill S. “Can renal replacement be deferred by a supplemented very low protein diet?” Journal of the American Society of Nephrology 10.1 (1999): 110-116.eng
dcterms.referencesGarneata L., et al. “SP334 Vegetarian very low protein diet supplemented with ketoanalogues may reduce nephrotic-range proteinuria in predialysis CKD patients”. Nephrology Dialysis Transplantation 31.1 (2016): i200-i213eng
dcterms.referencesNoce A., et al. “Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients?” Cell Death Discovery 2 (2016): 16026.eng
dcterms.referencesFouque D and Aparicio M. “Eleven reasons to control the protein intake of patients with chronic kidney disease”. Nature Reviews Nephrology 3 (2007): 383-392.eng
dcterms.referencesMusso CG and Macías-Núñez JF. “Renal aging and chronic kidney disease in the eldely: which are the differences?” In Musso CG, Jauregui JR, Macías-Núñez JF, Covic A (Eds). Clinical Nephrogeriatrics. An evidence-based guide. Cham. Springer (2019): 13-20.eng
dcterms.referencesMenon V., et al. “Effect of a very low-protein diet on outcomes: Long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study”. American Journal of Kidney Diseases 53 (2009): 208-217.eng
dcterms.referencesMalvy D., et al. “Effects of severe protein restriction with ketoanalogues in advanced renal failure”. Journal of the American College of Nutrition 18 (1999): 481-486.eng
oaire.versioninfo:eu-repo/semantics/publishedVersionspa

Archivos

Bloque original
Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
ALFA CETOANALOGOS PUBLICACION DIC 2022 ASNH-06-1156.pdf
Tamaño:
307.19 KB
Formato:
Adobe Portable Document Format
Descripción:
PDF
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
381 B
Formato:
Item-specific license agreed upon to submission
Descripción:

Colecciones